METTL3 and cancer: In contrast, and as discussed further in the next section, in cancer, METTL3-mediated m6A is thought to impair differentiation and promote carcinogenesis in a variety of cancer contexts [56], such as acute myeloid leukemia [57] and cutaneous squamous cell carcinoma [58].